Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jan;19(1):267-269.
doi: 10.1177/19322968241291877. Epub 2024 Nov 4.

Assessing Battery-Related Challenges in Insulin Pump Therapy: Insights From a Brazilian Diabetes Center

Affiliations

Assessing Battery-Related Challenges in Insulin Pump Therapy: Insights From a Brazilian Diabetes Center

Ana Lúcia Domingues Neves et al. J Diabetes Sci Technol. 2025 Jan.
No abstract available

Keywords: battery; continuous subcutaneous insulin infusion; diabetes mellitus; safety; type 1.

PubMed Disclaimer

Conflict of interest statement

Declaration of Conflicting InterestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1.
Figure 1.
Comparative analysis of Powerone and Energizer battery life in Roche and Medtronic CSIIs.

References

    1. Pozzilli P, Battelino T, Danne T, Hovorka R, Jarosz-Chobot P, Renard E. Continuous subcutaneous insulin infusion in diabetes: patient populations, safety, efficacy, and pharmacoeconomics. Diabetes Metab Res Rev. 2016;32(1):21-39. doi:10.1002/dmrr.2653. - DOI - PMC - PubMed
    1. Giani E. Impact of new technologies on diabetes care. World J Diabetes. 2015;6(8):999-1004. doi:10.4239/wjd.v6.i8.999. - DOI - PMC - PubMed
    1. Minicucci WJ. Uso de bomba de infusão subcutânea de insulina e suas indicações. Arq Bras Endocrinol Metabol. 2008;52(2):340-348. doi:10.1590/s0004-27302008000200022. - DOI - PubMed
    1. Murata T. Safety of the batteries and power units used in insulin pumps: a pilot cross-sectional study by the association for the study of innovative diabetes treatment in Japan. J. Diabetes Investig. 2018;9(4):903-907. doi:10.1111/jdi.12765. - DOI - PMC - PubMed
    1. Ross PL, Milburn J, Reith DM, Wiltshire E, Wheeler BJ. Clinical review: insulin pump-associated adverse events in adults and children. Acta Diabetol. 2015;52(6):1017-1024. doi:10.1007/s00592-015-0784-2. - DOI - PubMed

LinkOut - more resources